Luk Hugo Vandenberghe, Ph.D.
|Title||Assistant Professor of Ophthalmology|
|Institution||Massachusetts Eye and Ear Infirmary|
|Address||Schepens Eye Research Institute|
20 Staniford St
Boston MA 02114
(login for email)
The Vandenberghe laboratory deconstructs viral evolution to improve viral vector design and use in gene therapy. We aim to more profoundly understand capsid structure-function relationships and use this information to select and engineer gene therapy vectors for clinical indications.
For many of these studies, we use the ssDNA mammalian adeno-associated virus (AAV) as a model. AAV is not only one of the smallest and simplest mammalian viruses, it has also captivated the world of gene therapy as AAV, with remarkable efficiency and safety, is able to deliver and transduce genetic cargo into therapeutic target tissues such as the retina, cochlea, liver, and CNS. AAVs come in many flavors that were originally distinguished based on serology, but now are more and more phylogenetically and structurally defined. Different AAVs demonstrate very distinct phenotypes (tropism, receptor use, host response, assembly, etc.) as a wild type virus or replication-defective vector. We are interested in functionally and structurally understanding the mechanism of these stark differences from the perspective of virus as well as host. One avenue towards this goal is to study the evolutionary biology of this virus, and use mathematical, statistical, and systems approaches in combination with empirical and molecular methods to shed light on the structure-function relationship of these small, yet intricately complex infectious protein assemblies.
We aim at integrating these findings into improved technologies for therapeutic gene transfer, and use these findings and novel reagents toward building innovative therapies for diseases with unmet need, with a particular focus on blinding and hearing disorders.
lab webpage: http://www.vdb-lab.org/
Gene Transfer Vector Core: http://vector.meei.harvard.edu/
Available: 06/09/14, Expires: 05/01/18
This project aims at optimizing gene delivery to the retina and cochlea for therapeutic purposes. We aim to bring together surgical expertise and molecular engineering in order to achieve efficient and safe gene transfer to retinal subtypes including retinal ganglion, amacrine, bipolar, and photoreceptor cells. The technologies developed here will then be applied to models of blinding disorders in order to establish proof-of-concept of the treatment effect of a gene therapy.
This project requires a motivated individual with ambitions to become a physician-scientist and will be highly translational in nature. The role of the student will range from molecular biology procedures to animal studies, and may have opportunities to work with patient populations for which therapies are being build.
|This researcher has shared information about their research resources |
in the eagle-i Network. To update or add resource records, contact
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Click the "See All" links for more information and interactive visualizations!
People who are also in this person's primary department.